Company Filing History:
3 out of 38 
3 out of 5,081 
3 out of 154 
Years Active: 2015-2022
Title: Noëlie Campos: Innovator in Biomarker Research
Introduction
Noëlie Campos is a distinguished inventor based in Le Cres, France. He has made significant contributions to the field of biomarker research, particularly in the context of viral infections and retroviral diseases. With a total of three patents to his name, Campos is recognized for his innovative approaches to medical treatment and diagnostics.
Latest Patents
One of Campos's latest patents is focused on the use of miRNA-124 as a biomarker. This patent outlines the application of miR-124 in identifying viral infections and assessing the efficacy of therapeutic treatments for such infections. Another notable patent involves compounds that are useful for treating diseases caused by retroviruses. This patent describes methods for preventing or treating retroviral infections, excluding HIV, by utilizing specific chemical compounds that interact with cells to inhibit disease progression.
Career Highlights
Throughout his career, Noëlie Campos has worked with prominent organizations such as Abivax and the Centre National De La Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Campos has collaborated with notable colleagues, including Jamal Tazi and Romain Najman. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Noëlie Campos is a prominent figure in the field of biomarker research, with a focus on viral infections and retroviral diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options.